The common dementias: A pictorial review

European Radiology

Volumn 23, Issue 12, 2013, Pages 3405-3417

  Bhogal, Pervinder ^a   Mahoney, Colin ^b   Graeme Baker, Sophie ^a   Roy, Amit ^a   Shah, Sachit ^a   Fraioli, Francesco ^c   Cowley, Peter ^a   Jäger, Hans Rolf ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's; Dementia; Frontotemporal; Imaging; Lewy bodies

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; BIOCHEMICAL MARKER; FLUORODEOXYGLUCOSE F 18; IOFLUPANE I 123; NEUROLEPTIC AGENT; PITTSBURGH COMPOUND B; PRESENILIN 1; PRESENILIN 2; PROGRANULIN; TAU PROTEIN; TRACER;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTERIAL SPIN LABELLING; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN CORTEX ATROPHY; BRAIN METABOLISM; BRAIN PERFUSION; BRAIN SIZE; CADASIL; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DIFFUSION TENSOR IMAGING; EPISODIC MEMORY; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENE MUTATION; GENETIC RISK; GLUCOSE METABOLISM; HIPPOCAMPUS; HUMAN; MILD COGNITIVE IMPAIRMENT; MOLECULAR IMAGING; MULTIINFARCT DEMENTIA; MYOCARDIAL PERFUSION IMAGING; NERVE CELL LESION; NEUROPATHOLOGY; ONSET AGE; PARKINSON DISEASE; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RADIODIAGNOSIS; RATING SCALE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUSCEPTIBILITY WEIGHTED IMAGING; TEMPORAL LOBE; TEMPORAL LOBE ATROPHY; VASCULAR AMYLOIDOSIS; WHITE MATTER LESION;

ALZHEIMER DISEASE; ATROPHY; CEREBRAL CORTEX; DEMENTIA; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; DIFFUSION TENSOR IMAGING; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84890541757     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-3005-9     Document Type: Article

References (88)

1. Barkhof F, Fox NC, Bastos-Leite AJ, Scheltens P (2011) Neuroimaging in dementia. Springer, Heidelberg, pp 62-66
2. Farlow M (2007) Alzheimer's disease. Continuum Lifelong Learn Neurol 13:39-68
3. Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS (1981) Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 10:184-192
4. Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580
5. Braak H, Braak E (1994) Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 15:355-356, discussion 79-80
6. Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11:205-242
7. Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C (2009) Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 66:1151-1157
8. Jack CR Jr, Weigand SD, Shiung MM et al (2008) Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology 70:1740-1752
9. McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263-269
10. Jack CR Jr (2012) Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology 263:344-361
11. Jack CR Jr, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128
12. Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer's disease: occurrence, determinants and strategies toward intervention. Dialogues Clin Neurosci 11:111-128
13. Janssen JC, Beck JA, Campbell TA et al (2003) Early onset familial Alzheimer's disease: mutation frequency in 31 families. Neurology 60:235-239
14. St George-Hyslop PH, Tanzi RE, Polinsky RJ et al (1987) The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235:885-890
15. Davies P (1986) The genetics of Alzheimer's disease: a review and a discussion of the implications. Neurobiol Aging 7:459-466
16. Goate A, Chartier-Harlin MC, Mullan M et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706
17. Levy-Lahad E, Wasco W, Poorkaj P et al (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977
18. Sherrington R, Rogaev EI, Liang Y et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760
19. Scheuner D, Eckman C, Jensen M et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 2:864-780
20. Cavedo E, Boccardi M, Ganzola R et al (2011) Local amygdala structural differences with 3T MRI in patients with Alzheimer disease. Neurology 22:727-733
21. Jack CR Jr, Shiung MM, Gunter JL et al (2004) Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62:591-600
22. Jack CR Jr, Petersen RC, Xu Y et al (1998) Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 51:993-999
23. De Leon MJ, George AE, Golomb J et al (1997) Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 18:1-11
24. de Toledo-Morrell L, Dickerson B, Sullivan MP, Spanovic C, Wilson R, Bennett DA (2000) Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease. Hippocampus 10:136-142
25. Uotani C, Sugimori K, Kobayashi K (2006) Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease. Psychiatry Clin Neurosci 60:319-326
26. Scheltens P, Launer LJ, Barkhof F, Weinstein HC, van Gool WA (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 242:557-560
27. Wattjes MP, Henneman WJ, van der Flier WM et al (2009) Diagnostic imaging of patients in a memory clinic: comparison of MR imaging and 64-detector row CT. Radiology 253:174-183
28. Leung KK, Clarkson MJ, Bartlett JW, Clegg S, Jack CR Jr, Weiner MW, Fox NC, Ourselin S (2010) Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. Neuroimage 50:516-523
29. Klunk WE, Engler H, Nordberg A et al (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 55:306-319
30. Mathis CA, Kuller LH, Klunk WE et al (2013) In vivo assessment of amyloid-beta deposition in nondemented very elderly subjects. Ann Neurol 76:751-761
31. Musiek ES, Chen Y, Korczykowski M et al (2012) Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement 8:51-59
32. Yoshiura T, Hiwatashi A, Noguchi T et al (2009) Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer's disease. Eur Radiol 19:2819-2825
33. Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP (2011) A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 32:5-18
34. Mielke MM, Kozauer NA, Chan KC et al (2009) Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease. Neuroimage 46:47-55
35. Greicius MD, Srivastava G, Reiss AL, Menon V (2004) Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101:4637-4642
36. Filippini N, MacIntosh BJ, Hough MG et al (2009) Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A 106:7209-7214
37. Renner JA, Burns JM, Hou CE, McKeel DW Jr, Storandt M, Morris JC (2004) Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology 63:1175-1180
38. Tang-Wai DF, Graff-Radford NR, Boeve BF et al (2004) Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology 63:1168-1174
39. Lehmann M, Crutch SJ, Ridgway GR et al (2011) Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease. Neurobiol Aging 32:1466-1476
40. Whitwell JL, Jack CR Jr, Kantarci K et al (2007) Imaging correlates of posterior cortical atrophy. Neurobiol Aging 28:1051-1061
41. Koedam ELGE, Lehmann M, van der Flier WM et al (2011) Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 21:2618-2625
42. Wakai M, Honda H, Takahashi A, Kato T, Ito K, Hamanaka T (1994) Unusual findings on PET study of a patient with posterior cortical atrophy. Acta Neurol Scand 89:458-461
43. Iemolo F, Duro G, Rizzo C, Castiglia L, Hachinski V, Caruso C (2009) Pathophysiology of vascular dementia. Immun Ageing 6:13
44. Enciu AM, Constantinescu SN, Popescu LM, Muresanu DF, Popescu BO (2011) Neurobiology of vascular dementia. J Aging Res 2011:401604
45. Lee AY (2011) Vascular dementia. Chonnam Med J 47:66-71
46. Fratiglioni L, Rocca WA (2001) Epidemiology of dementia. In: Boller F, Cappa SF (eds) Handbook of neuropsychology, 2nd edn. Elsevier, Amsterdam, pp 193-215
47. O'Brien JT, Erkinjuntti T, Reisberg B et al (2003) Vascular cognitive impairment. Lancet Neurol 2:89-98
48. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F (2005) Poststroke dementia. Lancet Neurol 4:752-759
49. Korczyn AD, Vakhapova V, Grinberg LT (2012) Vascular dementia. J Neurol Sci 322:2-10
50. Ikeda M, Hokoishi K, Maki N et al (2001) Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology 57:839-844
51. Skoog I, Korczyn AD, Guekht A (2012) Neuroprotection in vascular dementia: a future path. J Neurol Sci 322:232-236
52. Koga H, Takashima Y, Murakawa R, Uchino A, Yuzuriha T, Yao H (2009) Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals. J Stroke Cerebrovasc Dis 18:32-37
53. van Straaten EC, Scheltens P, Knol DL, van Buchem MA, van Dijk EJ, Hofman PA et al (2003) Operational definitions for NINDS-AIREN criteria for vascular dementia. An interobserver study. Stroke 34:1907-1912
54. Wardlaw JM, Smith EE, Biessels GJ et al (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Lancet Neurol 12:822-838
55. Handley A, Medcalf P, Hellier K, Dutta D (2009) Movement disorders after stroke. Age Ageing 38:260-266
56. Udaka F, Sawada H, Kameyama M (2002) White matter lesions and dementia: MRI-pathological correlation. Ann N Y Acad Sci 977:411-415
57. Charidimou A, Werring DJ (2012) Cerebral microbleeds and cognition in cerebrovascular disease: an update. J Neurol Sci 322:50-55
58. Bastos-Leite AJ, Kuijer JP, Rombouts SA et al (2008) Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 29:1296-1301
59. Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG (2009) Cadasil. Lancet Neurol 8:643-653
60. Hansen L, Salmon D, Galasko D et al (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 40:1-8
61. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95:119-139
62. McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863-1872
63. Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22:1689-1707, quiz 837
64. Burton EJ, Karas G, Paling SM et al (2002) Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage 17:618-630
65. Marshall VL, Patterson J, Hadley DM, Grosset KA, Grosset DG (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Commun 27:933-937
66. McKeith I, O'Brien J, Walker Z et al (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305-313
67. Walker Z, Jaros E, Walker RW et al (2007) Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 78:1176-1181
68. Treglia G, Cason E (2012) Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with Lewy bodies and other dementias: a systematic review and a meta-analysis. J Neuroimaging 22:111-117
69. Gallucci M, Limbucci N, Catalucci A, Caulo M (2008) Neurodegenerative diseases. Radiol Clin North Am 46:799-817, vii
70. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82:476-486
71. Gorno-Tempini ML, Dronkers NF, Rankin KP et al (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55:335-346
72. Seelaar H, Kamphorst W, Rosso SM et al (2008) Distinct genetic forms of frontotemporal dementia. Neurology 71:1220-1226
73. Cairns NJ, Bigio EH, Mackenzie IR et al (2007) Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 114:5-22
74. Rohrer JD, Lashley T, Schott JM et al (2011) Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 134:2565-2581
75. Josephs KA (2007) Frontotemporal lobar degeneration. Neurol Clin 25:683-696, vi
76. Fukui T, Kertesz A (2000) Volumetric study of lobar atrophy in Pick complex and Alzheimer's disease. J Neurol Sci 174:111-121
77. Chan D, Fox NC, Scahill RI et al (2001) Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 49:433-442
78. Kipps CM, Davies RR, Mitchell J et al (2007) Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cogn Disord 23:334-342
79. Mahoney CJ, Beck J, Rohrer JD et al (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135:736-750
80. Rosen HJ, Gorno-Tempini ML, Goldman WP et al (2002) Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology 58:198-208
81. Du AT, Schuff N, Kramer JH et al (2007) Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 130:1159-1166
82. Foster NL, Heidebrink JL, Clark CM et al (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130:2616-2635
83. Vitali P, Migliaccio R, Agosta F et al (2008) Neuroimaging in dementia. Semin Neurol 28:467-483
84. Diehl-Schmid J, Grimmer T, Drzezga A et al (2007) Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging 28:42-50
85. Zhang Y, Schuff N, Du AT et al (2009) White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 132:2579-2592
86. Mahoney CJ, Malone IB, Ridgway GR et al (2013) White matter tract signatures of the progressive aphasias. Neurobiol Aging 34:1687-1699
87. Galantucci S, Tartaglia MC, Wilson SM et al (2011) White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain 134:3011-3029
88. Zhou J, Greicius MD, Gennatas ED et al (2010) Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 133:1352-1367